CYPH
CYPH
NASDAQ · Biotechnology

Cypherpunk Technologies Inc

$0.69
+0.09 (+14.03%)
As of Feb 8, 2:20 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +5,479.3% upside
Low Target $25.17
Average Target $38.72
High Target $55.57
Current Price $0.69
Current
$0.69
Target
$38.72
$25.17 $38.72 avg $55.57
Scenario Analysis
Bear Case
$25.17
3,526.8%
Low target
Base Case
$38.72
+5,479.3%
Avg target
Bull Case
$55.57
+7,907.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$49.27
-98.6% from high
52-Week Low
$27.11
+-97.4% from low
Target vs 52W High
$38.72
-21.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%